Novel Compounds as NLRP3 Inhibitors for Treating Alzheimer's Disease and Parkinson's Disease.
Rachel MataPublished in: ACS medicinal chemistry letters (2024)
Provided herein are novel compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such compounds in treating Alzheimer's disease and Parkinson's disease, and processes for preparing such compounds.
Keyphrases